Molina Healthcare, Inc. (NYSE:MOH) Shares Bought by Frank Rimerman Advisors LLC

Frank Rimerman Advisors LLC lifted its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 17,583.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,122 shares of the company’s stock after purchasing an additional 2,110 shares during the period. Frank Rimerman Advisors LLC’s holdings in Molina Healthcare were worth $631,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Innealta Capital LLC purchased a new stake in Molina Healthcare in the 2nd quarter valued at $36,000. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Molina Healthcare in the 2nd quarter valued at approximately $40,000. AM Squared Ltd purchased a new stake in shares of Molina Healthcare in the 2nd quarter valued at approximately $59,000. Mather Group LLC. purchased a new stake in shares of Molina Healthcare during the 1st quarter valued at approximately $123,000. Finally, Lindbrook Capital LLC grew its position in Molina Healthcare by 47.0% in the first quarter. Lindbrook Capital LLC now owns 322 shares of the company’s stock worth $132,000 after acquiring an additional 103 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CAO Maurice Hebert sold 393 shares of the stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Robert W. Baird began coverage on Molina Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $405.00 price target on the stock. TD Cowen reduced their price target on shares of Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research note on Wednesday, July 24th. JPMorgan Chase & Co. dropped their target price on shares of Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a report on Wednesday, July 10th. Wells Fargo & Company raised their price target on Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. Finally, Jefferies Financial Group decreased their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research note on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $378.00.

Molina Healthcare Stock Performance

Shares of MOH opened at $347.98 on Tuesday. The stock has a 50-day simple moving average of $336.88 and a 200-day simple moving average of $342.52. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. Molina Healthcare, Inc. has a 1 year low of $282.96 and a 1 year high of $423.92. The stock has a market capitalization of $20.39 billion, a PE ratio of 18.88, a PEG ratio of 1.20 and a beta of 0.57.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share for the quarter, beating analysts’ consensus estimates of $5.73 by $0.13. The business had revenue of $9.88 billion for the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company’s revenue was up 18.7% on a year-over-year basis. During the same period last year, the business earned $5.65 EPS. On average, analysts predict that Molina Healthcare, Inc. will post 23.5 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.